The U.S. Food and Drug Administration approves Gilead Sciences's new lenacapavir drug, marketed as Yeztugo, for the treatment of HIV after the drug successfully eliminated the infection in clinical trials. (NBC News), (AP) Management of HIV/AIDS link embed save